Novavax, Inc. (NVAX) Financial Articles

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials,... Read More

Industry: Biotechnology Sector: Healthcare

Novavax, Inc. (NVAX)

Uncomfortable See Alternatives

Business Score

Financial Score

ESG Score

Last updated: 3/10/2022

Report Summary

None of the business's revenue comes from Haram.
Interest is used but is not relied on to run the company.
The company has a net negative impact on at least one of the following: environment, society or governance.

What are Halal Investors' Comfort Levels?

Our Comfort Levels are based on our analysts’ latest review of a company's business, finances, and Environmental, Social and Governance (ESG) Impact. Our reports are not meant to be understood as a religious ruling (fatwa). Rather, they represent our best efforts in trying to identify whether a company is engaged in anything forbidden in Islam (haram) and to what extent. Based on our analysis, we determine our Comfort Level with investing in the company. We encourage readers to let us know if we missed anything in the comments and to voice their agreement/disagreement by leaving a thumbs up/down. Read more about our methodology.

Loading Articles...

Novavax, Inc. (NVAX) Financial Articles

Read the full report with business, financial, & ESG analysis

Members Only

What's included

Consider these free reports

Consider these instead

Get the latest reports & insights from Halal Investors. Sign up for our newsletter.